Navigation Links
Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract
Date:7/9/2008

BANGOR, Maine, July 9 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER) announced that it has sold ADCO South Medical Supplies, Inc., ("ADCO South") its Florida Medical-Surgical division. Nyer further announced that its pharmacy division, D.A.W. Inc., was awarded a two-year contract with Sunrise Senior Living, Inc. to be the preferred pharmacy provider at all 16 of the company's Assisted Living Facilities in Massachusetts. The award was made at the conclusion of a competitive proposal submission and review process. Residents at the facilities approximate 1,600.

"We strongly believe that the divestiture of ADCO South was in the best interest of the shareholders. Its operation provided no synergies to our core business and was at the same time geographically cumbersome," stated President and CEO Mark Dumouchel. "We are additionally enthusiastic about having been awarded preferred vendor status by the Sunrise Assisted Living team. The awarding of the contract by this first-class organization is consistent with our strategic goals of being the area's top pharmacy niche provider," Dumouchel further stated. "With the aging of the baby-boomer population, we foresee a rapidly expanding demand for the specialized services inherent in our core competence, and we will continue to adapt our company to meet the needs of the Assisted Living Community and other unique niches within the market."

About Nyer Medical Group

Nyer Medical Group, Inc. is a holding company that through its subsidiaries operates pharmacies in the greater Boston area and a medical products business that distributes and markets medical equipment and supply products to hospitals, physicians and nursing homes using relationship-based telemarketing
'/>"/>

SOURCE Nyer Medical Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Economic Stimulus Act Can Improve Medical Equipment Purchasing Power
2. Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic
3. Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment
4. Vivisimo Case Studies Detail Innovative Enterprise Search Applications by Medical Libraries, Womens Health Site
5. John McCains Record on Helping Families Facing Medical Bankruptcy: Bankrupt.
6. CRH Medical Corporation opens center in New Orleans, Louisiana
7. Mitigating Medical Identity Theft: AHIMA Journal Provides Patient Tools to Secure Health Information
8. Southern Home Medical Reports Its Encore Medical Staffing Division Increases Revenues by 63%
9. Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider.
10. Baron & Budd Attorney Denyse Clancy Speaks at International Mesothelioma Programs First Annual Harvard Medical School Course
11. Cleveland Clinic Physicians to Present at Medical Conference in Panama, July 11-12
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 1AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 1PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 2
Other Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10